Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Nov;12(11):7064-7068.
doi: 10.21037/jtd-2020-48.

Moderate aortic stenosis: a new actor has come into stage

Adriana Postolache  1 , Julien Tridetti  1 , Mai-Linh Nguyen Trung  1 , Raluca Dulgheru  1 , Cécile Oury  1 , Patrizio Lancellotti  1   2
Affiliations
Editorial

Moderate aortic stenosis: a new actor has come into stage

Adriana Postolache et al. J Thorac Dis. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-2020-48). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Staging and proposed follow-up plan in moderate aortic stenosis. The staging approach shown based on the presence of cardiac damage allows for the risk assessment of the individual patient with moderate AS and determines the timing of follow-up. BNP, brain natriuretic peptide; ECM, extracellular matrix assessed with CMR imaging T1 mapping; GLS, global longitudinal strain assessed by echocardiography using speckle-tracking; LA, left atrium; LGE, late gadolinium enhancement assessed with CMR; LV, left ventricular; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; RV, right ventricle; ST2, suppression of tumorigenicity 2 (marker of cardiac remodeling and myocardial fibrosis); TR, tricuspid regurgitation.
See this image and copyright information in PMC

Comment on

  • Poor Long-Term Survival in Patients With Moderate Aortic Stenosis.
    Strange G, Stewart S, Celermajer D, Prior D, Scalia GM, Marwick T, Ilton M, Joseph M, Codde J, Playford D; National Echocardiography Database of Australia contributing sites. Strange G, et al. J Am Coll Cardiol. 2019 Oct 15;74(15):1851-1863. doi: 10.1016/j.jacc.2019.08.004. Epub 2019 Sep 3. J Am Coll Cardiol. 2019. PMID: 31491546

References

    1. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91. 10.1093/eurheartj/ehx391 - DOI - PubMed
    1. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e1159-95. 10.1161/CIR.0000000000000503 - DOI - PubMed
    1. Tastet L, Tribouilloy C, Maréchaux S, et al. Staging Cardiac Damage in Patients With Asymptomatic Aortic Valve Stenosis. J Am Coll Cardiol 2019;74:550-63. 10.1016/j.jacc.2019.04.065 - DOI - PubMed
    1. Vannan MA, Pibarot P, Lancellotti P. Aortic Stenosis: The Emperor's New Clothes. J Am Coll Cardiol 2019;74:1864-7. 10.1016/j.jacc.2019.08.1029 - DOI - PubMed
    1. Lancellotti P, Vannan MA. Timing of intervention in aortic stenosis. N Engl J Med 2020;382:191-3. 10.1056/NEJMe1914382 - DOI - PubMed